IMPACT OF SGLT2 INHIBITORS ON MORTALITY IN PULMONARY ARTERIAL HYPERTENSION: EXPLORING THE ASSOCIATION
IRAKLI LEMONJAVA, Zurab Azmaiparashvili(Jefferson Hospital), Jose Manuel Martinez Manzano(Brigham and Women's Hospital), Nino Gudushauri(Einstein Medical Center Philadelphia), Irakli Tskhakaia(Jefferson Hospital)
Cited by 1
Related Papers
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|105
Single Cell RNA-seq and Mass Cytometry Reveals a Novel and a Targetable Population of Macrophages in Idiopathic Pulmonary Fibrosis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|48
A Tale of Two Proteolytic Machines: Matrix Metalloproteinases and the Ubiquitin–Proteasome System in Pulmonary Fibrosis
|International Journal of Molecular Sciences|2020|22
The use of intravenous tranexamic acid for patients with angiotensin-converting enzyme inhibitor–induced angioedema
|Annals of Allergy Asthma & Immunology|2021|10